Benchsci

Benchsci company information, Employees & Contact Information

Explore related pages

Related company profiles:

BenchSci’s vision is to exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient Ventures (Google’s AI fund), Inovia Capital, and TCV, our platform accelerates science at 16 of the top-20 pharmaceutical companies, and over 4,300 leading research centers worldwide. We’re a remote-first company recognized for our impact and culture as a Deloitte Tech Fast 50TM, CIX Top 10 Growth, and Great Place to Work®.

Company Details

Employees
355
Founded
-
Address
559 College St, 201,canada
Email
si****@****sci.com
Industry
Software Development
NAICS
Software Publishers
HQ
Toronto, Ontario
Looking for a particular Benchsci employee's phone or email?

Benchsci Questions

News

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform - Yahoo Finance

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform Yahoo Finance

BenchSci Partners with Thermo Fisher to Enhance R&D Productivity with AI Tools - SynBioBeta

BenchSci Partners with Thermo Fisher to Enhance R&D Productivity with AI Tools SynBioBeta

BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity - Business Wire

BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity Business Wire

BenchSci Expands Board of Directors with Appointment of Dr. Mikael Dolsten - Business Wire

BenchSci Expands Board of Directors with Appointment of Dr. Mikael Dolsten Business Wire

BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform - GlobeNewswire

BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform GlobeNewswire

BenchSci signs license agreement with Sanofi for drug development platform - Mobi Health News

BenchSci signs license agreement with Sanofi for drug development platform Mobi Health News

Artificial intelligence turns to antibody selection - Nature

Artificial intelligence turns to antibody selection Nature

BenchSci’s Liran Belenzon Moves Fast and Makes Things - The Healthcare Technology Report.

BenchSci’s Liran Belenzon Moves Fast and Makes Things The Healthcare Technology Report.

BenchSci trims headcount citing generative AI, economic conditions - BetaKit

BenchSci trims headcount citing generative AI, economic conditions BetaKit

BenchSci Launches AI Tool to Map Disease Biology for Preclinical Drug Discovery - Genetic Engineering and Biotechnology News

BenchSci Launches AI Tool to Map Disease Biology for Preclinical Drug Discovery Genetic Engineering and Biotechnology News

BenchSci Launches ‘Map’ of Biology Research Platform for Pharmaceutical Research - HIT Consultant

BenchSci Launches ‘Map’ of Biology Research Platform for Pharmaceutical Research HIT Consultant

With Google's backing, U of T startup BenchSci uses AI to create 'super scientists' - University of Toronto

With Google's backing, U of T startup BenchSci uses AI to create 'super scientists' University of Toronto

BenchSci raises $22 million for AI-powered drug discovery tools - Venturebeat

BenchSci raises $22 million for AI-powered drug discovery tools Venturebeat

COVID-19 risks to global food security - Science | AAAS

COVID-19 risks to global food security Science | AAAS

Netflix Culture Builder Jessica Neal Joins BenchSci Advisory Board - GlobeNewswire

Netflix Culture Builder Jessica Neal Joins BenchSci Advisory Board GlobeNewswire

BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND - Business Wire

BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND Business Wire

U of T drug discovery startup BenchSci ‘changing the tech world’: The Globe and Mail - University of Toronto

U of T drug discovery startup BenchSci ‘changing the tech world’: The Globe and Mail University of Toronto

BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind - GlobeNewswire

BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind GlobeNewswire

Google Veteran Bonita Stewart Joins BenchSci Board of Directors - GlobeNewswire

Google Veteran Bonita Stewart Joins BenchSci Board of Directors GlobeNewswire

Inovia Capital Partner and Former RIM CFO and COO Dennis Kavelman Joins BenchSci Board of Directors - GlobeNewswire

Inovia Capital Partner and Former RIM CFO and COO Dennis Kavelman Joins BenchSci Board of Directors GlobeNewswire

Former Shopify CTO Jean-Michel Lemieux joins BenchSci advisory board - BetaKit

Former Shopify CTO Jean-Michel Lemieux joins BenchSci advisory board BetaKit

BenchSci cuts 23% of jobs, becoming latest company to replace humans with AI - The Globe and Mail

BenchSci cuts 23% of jobs, becoming latest company to replace humans with AI The Globe and Mail

BenchSci To Expand Its Team Following Investment From Google’s AI Fund - Pulse 2.0

BenchSci To Expand Its Team Following Investment From Google’s AI Fund Pulse 2.0

BenchSci closes $95-million CAD Series D to expand AI drug-discovery platform - BetaKit

BenchSci closes $95-million CAD Series D to expand AI drug-discovery platform BetaKit

AI drug discovery startup BenchSci scores $63 million Series C round led by Inovia, TCV - BetaKit

AI drug discovery startup BenchSci scores $63 million Series C round led by Inovia, TCV BetaKit

BenchSci’s total funding reaches $27 million as Gradient ups investment - BetaKit

BenchSci’s total funding reaches $27 million as Gradient ups investment BetaKit

Toronto AI company BenchSci raises $50-million in quest to make science research faster and cheaper - The Globe and Mail

Toronto AI company BenchSci raises $50-million in quest to make science research faster and cheaper The Globe and Mail

BenchSci raises $29 million CAD Series B round - BetaKit

BenchSci raises $29 million CAD Series B round BetaKit

BenchSci Layoffs: 17% of staff axed, investing in generative AI - Samfiru Tumarkin LLP

BenchSci Layoffs: 17% of staff axed, investing in generative AI Samfiru Tumarkin LLP

Canadian life sciences company BenchSci sets up in Cambridge - Cambridge Independent

Canadian life sciences company BenchSci sets up in Cambridge Cambridge Independent

PhD Toolbox : 50 Essential Tools for Ph.D. Students in Biotech and Life Science - BioTecNika

PhD Toolbox : 50 Essential Tools for Ph.D. Students in Biotech and Life Science BioTecNika

Top Benchsci Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant